PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE

被引：0
|
作者：
Tarantolo, S. R. [1 ]
McSweeney, P. A. [2 ]
Micallef, I. N. M. [3 ]
Klein, L. M. [4 ]
Calandra, G. [5 ]
Huebner, D. [5 ]
机构：
[1] Nebraske Methodist Hosp, Omaha, NE USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
[3] Mayo Clin, Rochester, MN USA
[4] Advocate Lutheran Gen Hosp, Niles, IL USA
[5] Genzyme Corp, Cambridge, MA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
91
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] Bendamustine in advanced multiple myeloma previously treated with bortezomid and lenalidomide containing regimen
    Lehenbauer-Dehm, S.
    Alex, M.
    Pecher, G.
    Blau, I
    Eucker, J.
    Possinger, K.
    Scholz, C.
    ONKOLOGIE, 2012, 35 : 145 - 146
  • [42] Long-Term Treatment with Lenalidomide in Previously Treated Subjects with Multiple Myeloma
    Amor, A. A.
    Aguado, B.
    Camara, C.
    Velasco, A.
    Garcia-Escribano, F.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S68 - S69
  • [43] THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE
    Palmaro, A.
    Despas, F.
    Lapeyre-Mestre, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E65 - E65
  • [44] Lenalidomide and stem cell collection in patients with multiple myeloma
    Cook, R. J.
    Vogl, D.
    Mangan, P. A.
    Cunningham, K.
    Luger, S.
    Porter, D. L.
    Tsai, D. E.
    Raguza-Lopez, M.
    Wiley, K.
    Masters, K.
    Stadtmauer, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma
    Raja, Karthick Raja Muthu
    Kovarova, Lucie
    Hajek, Roman
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1406 - 1408
  • [46] Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide
    Kota Yoshifuji
    Takashi Toya
    Hiroto Adachi
    Masahiro Fujita
    Atsushi Wada
    Ryosuke Konuma
    Yuya Kishida
    Tatsuya Konishi
    Akihito Nagata
    Yuta Yamada
    Satoshi Kaito
    Takuma Kumagai
    Kyoko Inamoto
    Megumi Akiyama
    Aiko Igarashi
    Yuho Najima
    Noriko Doki
    Takeshi Kobayashi
    Kazuhiko Kakihana
    Hisashi Sakamaki
    Kazuteru Ohashi
    International Journal of Hematology, 2019, 110 : 115 - 118
  • [47] Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide
    Yoshifuji, Kota
    Toya, Takashi
    Adachi, Hiroto
    Fujita, Masahiro
    Wada, Atsushi
    Konuma, Ryosuke
    Kishida, Yuya
    Konishi, Tatsuya
    Nagata, Akihito
    Yamada, Yuta
    Kaito, Satoshi
    Kumagai, Takuma
    Inamoto, Kyoko
    Akiyama, Megumi
    Igarashi, Aiko
    Najima, Yuho
    Doki, Noriko
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (01) : 115 - 118
  • [48] Autograft of hematopoietic stem cells in multiple myeloma
    Harousseau, JL
    PRESSE MEDICALE, 2003, 32 (24): : 1107 - 1107
  • [49] Addition of Daratumumab to the combination of Bartezamib, Lenalidomide and Dexamethasone in Multiple Myeloma eligible for an autograft of hematopoietic stem cells
    Stocker, Nicolas
    HEMATOLOGIE, 2020, 26 (05): : 228 - 228
  • [50] Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies Including Plerixafor in Multiple Myeloma and Lymphoma Patients
    Ales, Tichopad
    Veronika, Vitova
    Zdenek, Koristek
    Daniel, Lysak
    JOURNAL OF CLINICAL APHERESIS, 2013, 28 (06) : 395 - 403
12345